Literature DB >> 26645426

CT differentiation of diffuse malignant peritoneal mesothelioma and peritoneal carcinomatosis.

Yu-Fei Liang1, Guo-Qi Zheng1, Yue-Feng Chen2, Hui Song1, Wen-Jie Yin1, Li Zhang2.   

Abstract

BACKGROUND AND AIM: Diffuse malignant peritoneal mesothelioma (DMPM) and peritoneal carcinomatosis (PC) have similar imaging in computer tomography (CT). We aimed to distinguish them.
METHODS: Computer tomography findings were evaluated in 48 DMPM and 47 PC for the peritoneal, mesenteric, omentum, lymph nodes, viscera infiltration, ascites and pleural plaques.
RESULTS: Two groups had no difference in terms of thickness, clinical manifestation, diameter of lymph nodes, ascites, and viscera infiltration. But they showed differences in the following: Ratio of asbestos exposure in DMPM group was higher. Smooth and irregular peritoneal thickening were more seen in DMPM group; peritoneal nodules were more commonly detected in PC group. Forty-eight cases of peritoneum in DMPM showed mild enhanced, while 14 patients in PC showed severe enhanced. Nodular type of omentum was more common in PC group than in DMPM group; omental cake was more commonly detected in DMPM group. Mesentery involvement was more commonly seen in DMPM group. Location of enlarged lymph nodes in cardiophrenic region was more frequently identified in DMPM, whereas location of enlarged lymph nodes in retroperitoneal region was more frequently identified in PC. Lymph nodes fusion was more frequently visualized in PC. Fixation of the intestinal wall was more common in DMPM. Pleural plaque was more common in DMPM. PC had distant metastasis except primary foci and peritoneum. In PC, tumor origins were ovary in 10, digestive system in 21, breast in one.
CONCLUSION: Using a combination of CT findings may increase our ability to distinguish PC from DMPM.
© 2015 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  X-ray computer; diffuse malignant peritoneal mesothelioma; peritoneal carcinomatosis; tomography

Mesh:

Year:  2016        PMID: 26645426     DOI: 10.1111/jgh.13260

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  9 in total

1.  Enhanced computed tomography imaging features predict tumor grade in pseudomyxoma peritonei.

Authors:  Pengtao Sun; Xinbao Li; Lingling Wang; Rengui Wang; Xuechao Du
Journal:  Quant Imaging Med Surg       Date:  2022-04

2.  Prognostic factors of malignant peritoneal mesothelioma: a retrospective study of 52 female patients.

Authors:  Jianting Ma; Shengzhi Zhang
Journal:  World J Surg Oncol       Date:  2022-06-29       Impact factor: 3.253

Review 3.  The role of imaging in diagnosis and management of malignant peritoneal mesothelioma: a systematic review.

Authors:  Bradley Carlson; Carla Harmath; Kiran Turaga; Hedy L Kindler; Samuel G Armato; Christopher Straus
Journal:  Abdom Radiol (NY)       Date:  2022-03-07

4.  Analysis of prognostic factors of patients with malignant peritoneal mesothelioma.

Authors:  Wenjie Yin; Guoqi Zheng; Kunna Yang; Hui Song; Yufei Liang
Journal:  World J Surg Oncol       Date:  2018-03-05       Impact factor: 2.754

5.  Significance of EGFR and PTEN Expression and PLR and NLR for Predicting the Prognosis of Epithelioid Malignant Peritoneal Mesothelioma.

Authors:  Yufei Liang; Guoqi Zheng; Wenjie Yin; Hui Song; Chunying Li; Liang Tian; Dongliang Yang
Journal:  Gastroenterol Res Pract       Date:  2019-02-04       Impact factor: 2.260

6.  Diffuse malignant peritoneal mesothelioma mimicking ovarian cancer.

Authors:  Zaynab Iraqi Houssaini; Hajar El Agouri; Sanae Amalik; Selma Khouchoua; Hounayda Jerguigue; Rachida Latib; Basma El Khannoussi; Youssef Omor
Journal:  Radiol Case Rep       Date:  2021-12-28

7.  CT imaging of malignant peritoneal mesothelioma: A case report.

Authors:  Agnes Triana Basja; M Hidayat Surya Atmaja
Journal:  Radiol Case Rep       Date:  2022-02-08

8.  Prognostic Significance of Blood, Serum, and Ascites Parameters in Patients with Malignant Peritoneal Mesothelioma or Peritoneal Carcinomatosis.

Authors:  Shan-Shan Su; Guo-Qi Zheng; Wen-Jie Yin; Yu-Fei Liang; Ying-Ying Liu; Hui Song; Ning-Ning Sun; Yu-Xin Yang
Journal:  Gastroenterol Res Pract       Date:  2018-02-15       Impact factor: 2.260

Review 9.  Localized biphasic malignant mesothelioma presenting as a giant pelvic wall mass: a rare case report and literature review.

Authors:  Yunsong Liu; Jingjun Wu; Ying Zhao; Pengxin Zhang; Zhengyu Hua; Wan Dong; Tao Lin; Ailian Liu
Journal:  BMC Med Imaging       Date:  2020-05-06       Impact factor: 1.930

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.